Advanced Instruments Acquires Solentim

August 5, 2021

Advanced Instruments has signed a definitive agreement to acquire Solentim for approximately USD 240 million, in a strategic add-on funded mainly with equity from Patricia Industries. The acquisition expands Advanced Instruments' bioprocessing instruments and consumables portfolio and combines complementary imaging, automation and single-cell cloning capabilities; Solentim is headquartered in Bournemouth, United Kingdom, and reported ~USD 17m revenue and ~USD 5m adjusted EBITDA for the 12 months to June 2021.

Buyers
Advanced Instruments, Patricia Industries (Investor AB)
Targets
Solentim
Platforms
Advanced Instruments
Industry
Medical Devices
Location
England, United Kingdom
Transaction Type
Addon

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.